Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sarasota, FL
NPI
1407054638
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1921 Waldemere St Ste 512
Sarasota, FL, 34239
Phone (941) 917-3270
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
91,650 services
Medicare patients, 2024
1,735
Average age 76
Drug cost, 2024
$192K
1,901 prescriptions
Company payments, 2025
$505
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angela T Boldo was code J0897 (injection, denosumab, 1 mg), 56,040 times for 550 patients. In total Angela T Boldo billed 91,650 services in 22 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 56,040 | 550 | $20.51 | $1.1M |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 31,620 | 48 | $8.55 | $270K |
| 96372 Injection Administration | Office | 1,083 | 593 | $10.82 | $12K |
| 99213 Office E&M - Established | Office | 1,012 | 721 | $64.77 | $66K |
| 99214 Office E&M - Established | Office | 870 | 753 | $87.16 | $76K |
| 99204 Office E&M - New | Office | 516 | 516 | $114.99 | $59K |
| 76536 Ultrasound - Nonspecific | Office | 224 | 216 | $76.46 | $17K |
| 10005 Other Organ Systems | Office | 143 | 137 | $98.37 | $14K |
| 99203 Office E&M - New | Office | 35 | 35 | $76.89 | $2,691 |
| 99205 Office E&M - New | Office | 21 | 21 | $126.53 | $2,657 |
| 99215 Office E&M - Established | Office | 21 | 20 | $122.82 | $2,579 |
| 99442 Telephone Services | Office | 21 | 20 | $66.60 | $1,399 |
| 10006 Other Organ Systems | Office | 19 | 18 | $46.98 | $893 |
By year: 2022 $818K for 46,163 services; 2023 $1.3M for 69,250 services; 2024 $1.7M for 91,650 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 369 | 304 | $2.97 | $1,095 |
| 82306 Clinical Chemistry | 245 | 215 | $29.29 | $7,175 |
| 84443 Clinical Chemistry | 195 | 157 | $16.61 | $3,239 |
| 84439 Clinical Chemistry | 193 | 155 | $8.92 | $1,721 |
| 84480 Clinical Chemistry | 119 | 100 | $13.99 | $1,665 |
| 83970 Clinical Chemistry | 93 | 88 | $40.87 | $3,801 |
| 82310 Clinical Chemistry | 83 | 79 | $5.12 | $425 |
Medicare prescription drug claims, 2024
In 2024, the drug Angela T Boldo prescribed most often to Medicare patients was Levothyroxine Sodium, with 612 prescriptions and refills. In total Angela T Boldo wrote 1,901 Medicare prescriptions that cost $192K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 612 | 1,818 | 199 | $5,189 |
| Ibandronate Sodium Generic | 376 | 1,105 | 134 | $13K |
| Synthroid Levothyroxine Sodium | 311 | 854 | 81 | $30K |
| Liothyronine Sodium Generic | 172 | 496 | 52 | $6,206 |
| Methimazole Generic | 110 | 307 | 40 | $1,189 |
| Alendronate Sodium Generic | 67 | 162 | 22 | $492 |
| Raloxifene Hcl Generic | 28 | 82 | 12 | $1,569 |
| Hydrochlorothiazide Generic | 24 | 72 | Under 11 | $112 |
| Tirosint Levothyroxine Sodium | 23 | 69 | Under 11 | $6,797 |
| Risedronate Sodium Generic | 23 | 68 | Under 11 | $2,512 |
| Chlorthalidone Generic | 14 | 42 | Under 11 | $280 |
| Levoxyl Levothyroxine Sodium | 12 | 36 | Under 11 | $721 |
| Prolia Denosumab | 11 | 66 | Under 11 | $20K |
Brand drugs: - claims; generic drugs: 1,150 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angela T Boldo $505 ($505 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novo Nordisk Inc with $71.05.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $71.05 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $54.5 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $54.44 |
| Dexcom, Inc. DXCM | 2 | $41.5 |
| Amgen Inc. AMGN | 2 | $38.35 |
| Insulet Corporation PODD | 1 | $36.09 |
| Recordati_rare_diseases_inc. | 1 | $31.59 |
| Corcept Therapeutics CORT | 1 | $28.01 |
| Sandoz Inc. SDZ.SW | 1 | $25.21 |
| Xeris Pharmaceuticals, Inc. | 1 | $22.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.